Ignite Creation Date:
2024-05-06 @ 4:12 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04901091
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2021-05-14
Brief Title:
Study of the Immediate and Long-term Outcomes of the Disease in Patients With Left Ventricular Aneurysm Complicated and Uncomplicated by Thrombosis After Transmural Myocardial Infarction According to the Hospital Registry SIBYL
Sponsor:
National Medical Research Center for Therapy and Preventive Medicine
Organization:
National Medical Research Center for Therapy and Preventive Medicine
Study Overview
Official Title:
Study of the Immediate and Long-term Outcomes of the Disease in Patients With Left Ventricular Aneurysm Complicated and Uncomplicated by Thrombosis After Transmural Myocardial Infarction According to the Hospital Registry
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SIBYL
Brief Summary:
A prospective non-interventional study aimed to evaluate the immediate and long-term outcomes in patients with left ventricular aneurysm after transmural myocardial infarction
A registry of patients with transmural myocardial infarction admitted to the Emergency Department of Cardiology will be created The registry will include all consecutive hospitalized patients from from January 1 2021 to December 31 2021 who meet the inclusion criteria Based on this registry patients will be divided into groups patients with left ventricular aneurysm and patients without aneurysm patients with left ventricular thrombosis and patients without thrombosis
Patients will be contacted in 3 and 12 months Surviving patients will be invited to appointment for an ECG echocardiography and survey The cardiovascular events during this period will be recorded
The factors determining the prognosis of patients and their concomitant diseases immediate and long-term prognoses therapeutic measures and drug therapy at the hospital and outpatient stages and patients adherence to therapy will be analyzed
A registry of patients with transmural myocardial infarction admitted to the Emergency Department of Cardiology will be created The registry will include all consecutive hospitalized patients from from January 1 2021 to December 31 2021 who meet the inclusion criteria Based on this registry patients will be divided into groups patients with left ventricular aneurysm and patients without aneurysm patients with left ventricular thrombosis and patients without thrombosis
Patients will be contacted in 3 and 12 months Surviving patients will be invited to appointment for an ECG echocardiography and survey The cardiovascular events during this period will be recorded
The factors determining the prognosis of patients and their concomitant diseases immediate and long-term prognoses therapeutic measures and drug therapy at the hospital and outpatient stages and patients adherence to therapy will be analyzed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None